Sepsis and Infectious Outcomes for GLP-r Agonists in CKD plus Type 2 Diabetes.
BACKGROUND Chronic kidney disease (CKD) is associated with a higher risk of sepsis and poorer clinical outcomes compared to the general population. While GLP-1 receptor agonists (GLP-1RA) may confer protective effects against sepsis beyond their metabolic benefits in patients with diabetes, their effect in CKD patients...